Fructose appears to exert a considerably greater impact on the onset of obesity and metabolic disturbances than previously recognized by the scientific community. This conclusion was reached by an international group of investigators, with their findings detailed in the journal Nature Metabolism.
By examining data from studies on common sweeteners—specifically table sugar and high-fructose corn syrup, both containing glucose and fructose—researchers deduced that fructose acts on the body in a unique manner.
Professor Richard Johnson from the University of Colorado states that fructose should not be viewed merely as a standard source of calories; rather, it functions as a metabolic signal that prompts fat storage via a pathway distinct from that used by glucose.
Information gathered during the investigation shows that the body processes fructose through metabolic routes that bypass some typical regulatory mechanisms. This results in intensified fat production, a reduction in the cell’s energy currency (ATP), and the accumulation of substances linked to metabolic dysfunctions.
Over time, these physiological shifts can escalate the probability of metabolic syndrome—a cluster of issues encompassing excess weight, insulin resistance, elevated blood pressure, and cardiac disease.
The researchers emphasize that fructose intake isn’t limited to consumption via food and beverages. Humans possess the capacity to synthesize fructose internally by converting glucose, rendering its effect on disease development more intricate than initially supposed.
The authors hypothesize that while fructose’s ability to encourage resource accumulation might have aided survival during periods of severe famine in the past, this very mechanism, when faced with today’s constant calorie surplus, now contributes to the development of chronic ailments.
About the Author
